Results 51 to 60 of about 3,765 (187)

The relationship between vaccination and uveitis: A comprehensive review of immune response, risk assessment, and clinical implications

Eye &ENT Research, Volume 2, Issue 1, Page 5-17, March 2025.
The review illustrates the possible immune responses provoked by diverse vaccines, encompassing the hepatitis B virus vaccine, human papillomavirus vaccine, measles‐mumps‐rubella combined vaccine, COVID‐19 vaccine and hepatitis A vaccine. These reponses span activation of the immune system, hypersensitivity reactions, molecular mimicry, and the role of
Yihan Zhang, Tianyu Tao, Zhaohuai Li, He Li, Qi Jiang, Lei Zhu, Wenru Su   +6 more
wiley   +1 more source

CMV proctitis mimicking a rectal tumor

ANZ Journal of Surgery, EarlyView.
Wei Ming Ong, Perry Lindsay, Suat Chin Ng, David Machet, Vinna An   +4 more
wiley   +1 more source

Lipschütz ulcer following first dose of COVID‐19 tozinameran vaccine: Report of a case and review of a World Health Organization pharmacovigilance database

International Journal of Gynecology &Obstetrics, Volume 168, Issue 3, Page 958-964, March 2025.
Abstract Lipschütz ulcer (LU) is a condition known for painful vulvar ulcers, typically affecting young women and often linked to infectious agents. Recent reports have indicated a potential connection between LU and COVID‐19 vaccination, particularly after the second or booster doses.
Elliot Ewig, Nouha Ben Othman, Delphine Viard, Pierre‐Alexis Gauci, Fanny Rocher, Milou‐Daniel Drici   +5 more
wiley   +1 more source

MODERN ETHIOTROPIC CHEMOTHERAPY OF HERPESVIRUS INFECTIONS: ADVANCES, NEW TRENDS AND PERSPECTIVES. ALPHAHERPESVIRUSES (PART II)

Вопросы вирусологии, 2018
A key role in the treatment of herpesviral infections is played by modified nucleosides and their predecessors - acyclovir, its L-valine ester (valaciclovir) and famciclovir (prodrug of penciclovir).
V. L. Andronova
doaj   +1 more source

Ramsay-Hunt syndrome

PAMJ Clinical Medicine, 2020
A 27-year-old man consulting in the emergency room for an acute facial paralysis with deafness and vertigo for 4 days. Physical examination shows clustered vesicles in the external auditory canal without any oral involvement.
Ilyass Anouar, Naoufal Hjira
doaj   +1 more source

Tofacitinib for the treatment of chronic pouchitis: A pilot study

United European Gastroenterology Journal, Volume 13, Issue 2, Page 201-209, March 2025.
Tofacitinib achieved clinical remission in 31% of chronic pouchitis patients after 8 weeks, of treatment, with significant reductions in total and clinical PDAI scores but no significant changes in endoscopic or histologic disease activity. Abstract Background & Aims Up to 15% of ulcerative colitis (UC) patients with an ileo‐anal pouch will develop ...
Djuna C. de Jong, Rogier Goetgebuer, Bart L. M. Müskens, E. Andra Neefjes‐Borst, Krisztina B. Gecse, Mark Löwenberg, Wouter de Jonge, Willem Bemelman, Cyriel Ponsioen, Geert R. D'Haens, Marjolijn Duijvestein   +10 more
wiley   +1 more source

Navigating methotrexate toxicity: Examining the therapeutic roles of folinic acid and glucarpidase

British Journal of Clinical Pharmacology, Volume 91, Issue 3, Page 628-635, March 2025.
Methotrexate (MTX) toxicity varies depending on factors such as dosing frequency (acute or repeated), dosage (low or high) and the administration route (oral, parenteral or intrathecal). Renal impairment can trigger or exacerbate MTX toxicity. Acute oral low‐dose MTX (LDMTX) overdoses seldom lead to toxicity due to the saturable maximal bioavailable ...
Betty S. Chan, Annmarie A. Bosco, Nicholas A. Buckley   +2 more
wiley   +1 more source

Neoplasia Peniana: Diagnóstico Mascarado por Inibidores do SGLT2

Gazeta Médica, 2023
O cancro do pénis é uma neoplasia rara que se pode apresentar com uma variada gama de sintomas. Quando diagnosticado precocemente tem um excelente prognóstico, contudo, este piora dramaticamente na presença de metástases.
Ana João Silva, José Guilherme Pereira, Hugo Cadavez   +2 more
doaj  

Single‐center off‐label benralizumab use for refractory hypereosinophilic syndrome demonstrates satisfactory safety and efficacy

eJHaem, Volume 6, Issue 1, February 2025.
Abstract Introduction Benralizumab is an interleukin 5‐receptor‐blocking drug registered for the treatment of eosinophilic asthma. It has proven efficient and safe in a small phase‐II trial in hypereosinophilic syndrome and is currently being investigated in a larger, randomized phase‐III trial.
Yvonne Veltman, Anna M. Aalbers, Maud A. W. Hermans, Pim G. N. J. Mutsaers   +3 more
wiley   +1 more source

Herpes zoster development in living kidney transplant recipients receiving low‐dose rituximab

International Journal of Urology, Volume 32, Issue 1, Page 88-93, January 2025.
Objectives We evaluated whether a history of low‐dose rituximab treatment affected herpes zoster development after living kidney transplantation. Methods We enrolled 103 living kidney transplant recipients. Patients were divided into two groups according to their history of rituximab treatment; rituximab was administered to 50 living kidney transplant ...
Hayato Nishida, Hiroki Fukuhara, Satoshi Takai, Takaaki Nawano, Tomohiro Takehara, Takafumi Narisawa, Hidenori Kanno, Mayu Yagi, Atsushi Yamagishi, Sei Naito, Norihiko Tsuchiya   +10 more
wiley   +1 more source